---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-031989"
form_type: "8-K"
ticker: "NTLA"
cik: "0001652130"
company_name: "Intellia Therapeutics, Inc."
filed_at: "2025-02-21T23:59:59+00:00"
generated_at: "2026-05-26T06:56:59.448710+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Intellia signs 12-year Cambridge lease for ~147K sq ft; terminates Waltham lease with $78M payment

## Summary
- New lease at 400 Technology Square, Cambridge: initial 101K sq ft, expandable to ~147K sq ft in two tranches starting Dec 2027.
- Base rent $108/sq ft/year, 3% annual escalations; landlord provides up to $41.5M for tenant improvements.
- Winter Street lease terminated with $78M paid in three installments (Feb 2025, Apr 2025, Jan 2026); no rent due after Jan 2025.
- Lease term 12 years 3 months plus 5-year extension option; occupancy starts Jul 2025, rent begins ~14 months later.

## SEC filing metadata
- accession: 0001193125-25-031989
- form_type: 8-K
- ticker: NTLA
- cik: 0001652130
- company_name: Intellia Therapeutics, Inc.
- filed_at: 2025-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652130/000119312525031989/0001193125-25-031989-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652130/000119312525031989/d860657d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-031989
- JSON: https://secwatch.observer/filing/0001193125-25-031989.json
- Plain text: https://secwatch.observer/filing/0001193125-25-031989.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.